Cargando…

Does the New FIGO 2018 Staging System Allow Better Prognostic Differentiation in Early Stage Cervical Cancer? A Dutch Nationwide Cohort Study

SIMPLE SUMMARY: The introduction of a revised staging system (FIGO 2018 staging system) for cervical cancer has led to a significant change in stage allocation for patients with early stage disease. It remains unclear how this change should be translated into treatment options, including less extens...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ten Eikelder, Mieke L. G., Hinten, Floor, Smits, Anke, Van der Aa, Maaike A., Bekkers, Ruud L. M., IntHout, Joanna, Wenzel, Hans H. B., Zusterzeel, Petra L. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9265081/ https://www.ncbi.nlm.nih.gov/pubmed/35804912 http://dx.doi.org/10.3390/cancers14133140

Ejemplares similares

High- or Intermediate-Risk Histologic Features in Patients with Clinical Early-Stage Cervical Cancer Planned for Fertility-Sparing Surgery: A Systematic Review
por: Wolswinkel, Janneke T., et al.
Publicado: (2023)

Para-aortic lymphadenectomy in advanced stage cervical cancer, a protocol for comparing safety, feasibility and diagnostic accuracy of surgical staging versus PET-CT; PALDISC trial
por: Tax, Casper, et al.
Publicado: (2018)

Neoadjuvant Chemotherapy Followed by Vaginal Radical Trachelectomy as Fertility‐Preserving Treatment for Patients with FIGO 2018 Stage 1B2 Cervical Cancer
por: Zusterzeel, Petra L.M., et al.
Publicado: (2020)

External validation of three prognostic models for overall survival in patients with advanced-stage epithelial ovarian cancer
por: van de Laar, R, et al.
Publicado: (2014)

The relative risk of noncervical high‐risk human papillomavirus‐related (pre)malignancies after recurrent cervical intraepithelial neoplasia grade 3: A population‐based study
por: Loopik, Diede L., et al.
Publicado: (2019)

FIGO staging of endometrial cancer: 2023
por: Berek, Jonathan S., et al.
Publicado: (2023)

Survival analysis of revised 2013 FIGO staging classification of epithelial ovarian cancer and comparison with previous FIGO staging classification
por: Paik, E Sun, et al.
Publicado: (2015)

FIGO staging in ovarian carcinoma and histological subtypes
por: Kehoe, Sean
Publicado: (2020)

FIGO staging for carcinoma of the vulva: 2021 revision
por: Olawaiye, Alexander B., et al.
Publicado: (2021)

Reviewing FIGO 2018 cervical cancer staging
por: Soares, Leila Cristina, et al.
Publicado: (2023)

Impact of a nutritional supplement (Impryl) on male fertility: study protocol of a multicentre, randomised, double-blind, placebo-controlled clinical trial (SUppleMent Male fERtility, SUMMER trial)
por: Smits, Roos, et al.
Publicado: (2020)

The added value of SLN mapping with indocyanine green in low- and intermediate-risk endometrial cancer management: a systematic review and meta-analysis
por: Burg, Lara C., et al.
Publicado: (2022)

Implications of the revised cervical cancer FIGO staging system
por: Bhatla, Neerja, et al.
Publicado: (2021)

Critical analysis of the FIGO 2018 cervical cancer staging
por: Soares, Leila Cristina, et al.
Publicado: (2022)

Can MRI Be Used as a Sole Diagnostic Modality in Determining Clinical Stage in Cervical Cancer?
por: Smits, Anke, et al.
Publicado: (2022)

Clinical Outcome of a FIGO Stage IV Gestational Choriocarcinoma
por: Milenković, Vera, et al.
Publicado: (2013)

Data from small cell neuroendocrine carcinoma of the cervix: FIGO 2018 staging is more accurate than FIGO 2009
por: Zhang, Yunqiang, et al.
Publicado: (2022)

Adjuvant brachytherapy for FIGO stage I serous or clear cell endometrial cancer
por: Jeans, Elizabeth B, et al.
Publicado: (2021)

Validation of the 2018 FIGO Staging System for Predicting the Prognosis of Patients With Stage IIIC Cervical Cancer
por: Long, Xingtao, et al.
Publicado: (2023)

The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method
por: IntHout, Joanna, et al.
Publicado: (2014)

Peer review comments on drug trials submitted to medical journals differ depending on sponsorship, results and acceptance: a retrospective cohort study
por: van Lent, Marlies, et al.
Publicado: (2015)

Sacrospinous hysteropexy versus vaginal hysterectomy with uterosacral ligament suspension in women with uterine prolapse stage 2 or higher: observational follow-up of a multicentre randomised trial
por: Schulten, Sascha F M, et al.
Publicado: (2019)

Radical hysterectomy for FIGO stage I–IIB adenocarcinoma of the uterine cervix
por: Kasamatsu, T, et al.
Publicado: (2009)

FIGO good clinical practice paper: management of the second stage of labor
por: Wright, Alison, et al.
Publicado: (2021)

Vulvar Cancer: 2021 Revised FIGO Staging System and the Role of Imaging
por: Virarkar, Mayur, et al.
Publicado: (2022)

A Suggested Modification to FIGO Stage IV Epithelial Ovarian Cancer
por: Métairie, Marie, et al.
Publicado: (2023)

The risk of lymph node metastasis in the new FIGO 2018 stage IA cervical cancer with >7 mm diameter
por: Nicolai, Laure, et al.
Publicado: (2023)

FIGO Staging for Uterine Sarcomas: Can the Revised 2008 Staging System Predict Survival Outcome Better?
por: Yim, Ga Won, et al.
Publicado: (2014)

A Risk Stratification for Patients with Cervical Cancer in Stage IIIC1 of the 2018 FIGO Staging System
por: Liu, Xiaoliang, et al.
Publicado: (2020)

Sacrospinous hysteropexy versus vaginal hysterectomy with suspension of the uterosacral ligaments in women with uterine prolapse stage 2 or higher: multicentre randomised non-inferiority trial
por: Detollenaere, Renée J, et al.
Publicado: (2015)

Prognostic factors and a value of 2009 FIGO staging system in vulvar cancer
por: Sznurkowski, Jacek J., et al.
Publicado: (2012)

FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum: abridged republication
por: Prat, Jaime
Publicado: (2015)

Multidisciplinary perspectives on newly revised 2018 FIGO staging of cancer of the cervix uteri
por: Berek, Jonathan S., et al.
Publicado: (2018)

Risk Stratification of Endometrial Cancer Patients: FIGO Stage, Biomarkers and Molecular Classification
por: Kasius, Jenneke C., et al.
Publicado: (2021)

Validation of the 2018 FIGO Staging System of Cervical Cancer for Stage III Patients with a Cohort from China
por: Liu, Xiaoliang, et al.
Publicado: (2020)

Subjective outcomes 12 years after transvaginal mesh versus native tissue repair in women with recurrent pelvic organ prolapse; a randomized controlled trial
por: Kluivers, Kirsten B., et al.
Publicado: (2023)

Should the Number of Metastatic Pelvic Lymph Nodes Be Integrated into the 2018 Figo Staging Classification of Early Stage Cervical Cancer?
por: Pedone Anchora, Luigi, et al.
Publicado: (2020)

FIGO 2018 Staging for Cervical Cancer: Influence on Stage Distribution and Outcomes in the 3D-Image-Guided Brachytherapy Era
por: Tomizawa, Kento, et al.
Publicado: (2020)

Influence of New FIGO 2018 Staging on Treatment Outcomes in Early-Stage Cervical Cancer: A Single-Center Study
por: Kaur, Satinder, et al.
Publicado: (2022)

Pretreatment risk factors for parametrial involvement in FIGO stage IB1 cervical cancer
por: Yamazaki, Hiroyuki, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_cfkbtogbj6t934rj8t751jn26i